What is the treatment for a fungal corneal ulcer with hypopyon?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Fungal Corneal Ulcer with Hypopyon

Initiate topical natamycin 5% (NATACYN®) one drop hourly or every two hours as first-line therapy for fungal keratitis with hypopyon, and obtain corneal scrapings for culture and sensitivity testing before starting treatment to guide subsequent therapy. 1

Immediate Management Algorithm

Initial Diagnostic Steps

  • Obtain corneal scrapings immediately using proparacaine 0.5% anesthetic (avoid tetracaine due to antimicrobial effects) from the base and periphery of the ulcer before initiating antifungal therapy 2, 3
  • Inoculate samples directly onto fungal culture media (Sabouraud agar) and perform KOH/Calcofluor white staining to visualize fungal elements 2
  • Do NOT tap the hypopyon - it is typically sterile in fungal keratitis unless there is concurrent endophthalmitis from trauma or surgery 2

First-Line Antifungal Therapy

Natamycin 5% is the only FDA-approved topical antifungal for fungal keratitis and should be started immediately 1:

  • Loading phase: 1 drop hourly or every 2 hours for the first 3-4 days 1
  • Maintenance phase: Reduce to 1 drop 6-8 times daily after initial improvement 1
  • Duration: Continue for 14-21 days or until complete resolution of active infection 1
  • Gradual taper: Reduce dosage at 4-7 day intervals to ensure organism elimination 1

Alternative and Adjunctive Antifungal Options

If natamycin fails or for specific organisms, consider these alternatives based on culture results:

  • Voriconazole shows the lowest minimum inhibitory concentration (MIC) against most fungal pathogens and may be superior to natamycin, particularly for Aspergillus species 4, 5
  • Amphotericin B 0.15-0.3% topical ointment or drops can be compounded for resistant cases, especially Aspergillus fumigatus and Fusarium solani 6
  • Intracameral amphotericin B (5-10 μg/0.1 mL sterile water) or voriconazole (100 μg/0.1 mL) may be necessary for severe cases with deep stromal involvement 2, 5

Critical Management Considerations

Organism-Specific Treatment Adjustments

  • Aspergillus species: Higher natamycin MIC values warrant early consideration of voriconazole or amphotericin B 4
  • Fusarium species: Natamycin is FDA-approved specifically for Fusarium solani keratitis 1
  • Candida species: May present with ring infiltrates and hypopyon; consider fluconazole 400-800 mg daily orally for susceptible isolates 2, 7

Adjunctive Medical Therapy

  • Cycloplegics (atropine 1% or homatropine 5%) to reduce pain and prevent synechiae formation 3
  • Oral doxycycline or minocycline (100 mg twice daily) to inhibit matrix metalloproteinases and reduce corneal melting risk 2
  • AVOID topical corticosteroids initially - fungal keratitis has worse outcomes than bacterial keratitis with higher perforation rates 2
  • Steroids may be considered cautiously only after definitive fungal identification, confirmed response to antifungals, and ruling out Nocardia 3, 5

Surgical Interventions for Complicated Cases

Indications for Surgical Management

Consider surgical intervention when:

  • Progressive stromal thinning despite maximal medical therapy 2
  • Impending or frank corneal perforation 2
  • Large corneal perforation requiring structural support 2
  • Unresponsive disease after 7-10 days of appropriate antifungal therapy 2

Surgical Options

  • Amniotic membrane transplantation: May stabilize the ocular surface and improve outcomes, though it does not reduce hypopyon size or duration 2
  • Therapeutic penetrating keratoplasty: For large perforations or progressive disease; send excised tissue for pathology and culture 2
  • Tissue adhesive with bandage contact lens: For small perforations with good surrounding tissue 2
  • Tenon's patch graft with cyanoacrylate glue: Effective for larger perforations 2

Monitoring and Follow-Up Protocol

  • Daily examination initially until clear clinical improvement is documented 3
  • Reassess at 3-4 days: If no improvement, reculture after stopping antifungals for 12-24 hours 2
  • Expect slower healing: Fungal keratitis has slower re-epithelialization and higher perforation rates compared to bacterial keratitis 2
  • Continue treatment for minimum 14-21 days even with clinical improvement to prevent relapse 1

Common Pitfalls to Avoid

  • Do not delay corneal scraping - clinical differentiation between bacterial and fungal keratitis is correct in less than 70% of cases by experienced cornea specialists 2
  • Do not use preserved anesthetics or cycloplegics before obtaining cultures as they reduce culture yield 2
  • Do not start corticosteroids early - this is particularly dangerous in fungal keratitis and can lead to rapid progression 3, 5
  • Do not assume natamycin will work for all fungi - Aspergillus species may require voriconazole or amphotericin B from the outset 4
  • Do not stop treatment too early - gradual taper over 4-7 day intervals is essential to prevent recurrence 1

Fungal keratitis with hypopyon represents a sight-threatening emergency requiring aggressive initial therapy, close monitoring, and low threshold for surgical intervention given the higher perforation rates and worse visual outcomes compared to bacterial keratitis. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Corneal Ulcers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Keratomycosis: diagnosis and therapy].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2009

Research

Treatment of fungal corneal ulcers with amphotericin B ointment.

American journal of ophthalmology, 1997

Research

[Fungal keratitis with annular infiltration and hypopyon].

Journal francais d'ophtalmologie, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.